MAJOR MILESTONES
Lupin has posted steady U.S. growth and a continually expanding pipeline of new products and initiatives since establishing its U.S. base of operations.
Cool Timeline
Lupin Pharmaceuticals Inc. founded in Baltimore, Maryland for marketing and developmental activities in the U.S.
Generics business launched in the U.S. with 5 products
Emerges as the 5th largest manufacturer player in the U.S.
Lupin announces new Center of Excellence facility for Inhalation Research in Coral Springs, Florida
By acquiring Novel Laboratories, Inc. Lupin created Lupin Somerset, Lupin’s first U.S.- based commercial manufacturing facility
Fiscal year 2017 marked a milestone for Lupin as our U.S. revenues surpassed the USD 1 billion mark; a growth of 37% over fiscal year 2016 (revenues FY2017 were $1,207 million vs. $883 million in FY2016)
Solosec® (secnidazole) launched in the U.S.
